815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment

U. Gatzemeier; F. De Marinis; C. Manegold; P. Mali; L. Portalone; O. Castelnau; R. Stahel; D. Betticher; J.Terrassa Pons; C. Gridelli

doi:10.1016/s1359-6349(03)90840-8

815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90840-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S244-S245

Author(s):

U. Gatzemeier ◽

F. De Marinis ◽

C. Manegold ◽

P. Mali ◽

L. Portalone ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e18013 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e18013-e18013

Author(s):

H. Terai ◽

K. Soejima ◽

M. Nakamura ◽

K. Naoki ◽

H. Yasuda ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Cited By ~ 4

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2018-0858 ◽

2018 ◽

Vol 24 (4) ◽

pp. 459 ◽

Cited By ~ 2

Author(s):

Akihiro Yoshimura ◽

Yusuke Chihara ◽

Koji Date ◽

Nobuyo Tamiya ◽

Yoshizumi Takemura ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

Anticancer Research ◽

10.21873/anticanres.12661 ◽

2018 ◽

Vol 38 (6) ◽

pp. 3779-3784 ◽

Cited By ~ 1

Author(s):

HIROAKI TAKEOKA ◽

KAZUHIKO YAMADA ◽

YOSHIKO NAITO ◽

NORIKAZU MATSUO ◽

HIDENOBU ISHII ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(97)85866-2 ◽

1997 ◽

Vol 33 ◽

pp. S236 ◽

Cited By ~ 1

Author(s):

N. Androulakis ◽

C. Kourousis ◽

S. Kakolyris ◽

A.M. Dimopoulos ◽

E. Papadakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

Lung Cancer ◽

10.1016/s0169-5002(03)91937-4 ◽

2003 ◽

Vol 41 ◽

pp. S81-S82

Author(s):

Filippo De Marinis ◽

Cesare Gridelli ◽

Marco Lombardo ◽

Luca Paoluzzi ◽

Francisco Ferraù ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Multicenter phase II study of the combination of carboplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7239 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7239-7239 ◽

Cited By ~ 4

Author(s):

I. Okamoto ◽

E. Moriyama ◽

H. Kishi ◽

M. Nomura ◽

F. Imamura ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7073 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7073-7073 ◽

Cited By ~ 10

Author(s):

G. Giaccone ◽

T. Lechevalier ◽

N. Thatcher ◽

E. Smit ◽

M. Janmaat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Docetaxel plus fractionated cisplatin is a safe and active schedule as first-line treatment of patients with advanced non-small cell lung cancer: Results of a phase II study

Investigational New Drugs ◽

10.1023/b:drug.0000036691.30244.46 ◽

2004 ◽

Vol 22 (4) ◽

pp. 481-487 ◽

Cited By ~ 8

Author(s):

José Luis Firvida ◽

Margarita Amenedo ◽

Rubén Rodríguez ◽

Ana González ◽

Mercedes Salgado ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Active Schedule ◽

First Line Treatment

Download Full-text

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2013.01.008 ◽

2013 ◽

Vol 80 (2) ◽

pp. 185-190 ◽

Cited By ~ 22

Author(s):

Radj Gervais ◽

Gilles Robinet ◽

Christelle Clément-Duchêne ◽

Fabrice Denis ◽

Claude El Kouri ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text